Transmitted resistant HIV may revert to wild-type in the absence of drug pressure due to reduced replication capacity (RC). We observed eight therapy-naive patients infected with HIV harbouring four mutations at nucleoside reverse transcriptase inhibitor (NRTI) resistance-related positions: M41L, T69S, L210E and T215S. If partial reverted resistance patterns like these are detected at baseline, concerns for more extensive resistance in the quasispecies often directs selection of first-line combination antiretroviral therapy (cART) towards more complex regimens.Genotypic resistance testing and phylogenetic analysis was performed using pol sequences of 400 therapy-naive patients and 1322 patients with at least one NRTI-related mutation. Rever...
The effects of drug resistance on HIV-1 replication capacity have been studied, but data from clinic...
We evaluated the predictive value of baseline HIV-1 genotypic resistance mutations for failure of a ...
We characterized 16 additional mutations in human immunodeficiency virus type 1 (HTV-1) reverse tran...
Transmitted resistant HIV may revert to wild-type in the absence of drug pressure due to reduced rep...
Evolution and transmission of multiply drug-resistant human immunodeficiency virus type 1 (HIV-1) ma...
The human immunodeficiency virus (HIV) is the primary etiologic agent of the acquired immunodeficien...
BACKGROUND: The Q151M multi-drug resistance (MDR) pathway in HIV-1 reverse transcriptase (RT) confer...
textabstractBackground: In approximately 10% of newly diagnosed individuals in Europe, HIV-1 variant...
We characterized 16 additional mutations in human immunodeficiency virus type 1 (HIV-1) reverse tran...
Transmission of human immunodeficiency virus (HIV) drug resistance is well-recognized and compromise...
We characterized 16 additional mutations in human immunodeficiency virus type 1 (HIV-1) reverse tran...
OBJECTIVE: Antiretroviral-naive HIV-positive individuals contribute to the transmission of drug-resi...
Background. Drug resistance mutations (DRMs) can serve as distinct, nonpolymorphic markers for evalu...
International audienceOBJECTIVE:Antiretroviral-naive HIV-positive individuals contribute to the tran...
OBJECTIVES: To monitor HIV-1 transmitted drug resistance (TDR) in a well defined urban area with lar...
The effects of drug resistance on HIV-1 replication capacity have been studied, but data from clinic...
We evaluated the predictive value of baseline HIV-1 genotypic resistance mutations for failure of a ...
We characterized 16 additional mutations in human immunodeficiency virus type 1 (HTV-1) reverse tran...
Transmitted resistant HIV may revert to wild-type in the absence of drug pressure due to reduced rep...
Evolution and transmission of multiply drug-resistant human immunodeficiency virus type 1 (HIV-1) ma...
The human immunodeficiency virus (HIV) is the primary etiologic agent of the acquired immunodeficien...
BACKGROUND: The Q151M multi-drug resistance (MDR) pathway in HIV-1 reverse transcriptase (RT) confer...
textabstractBackground: In approximately 10% of newly diagnosed individuals in Europe, HIV-1 variant...
We characterized 16 additional mutations in human immunodeficiency virus type 1 (HIV-1) reverse tran...
Transmission of human immunodeficiency virus (HIV) drug resistance is well-recognized and compromise...
We characterized 16 additional mutations in human immunodeficiency virus type 1 (HIV-1) reverse tran...
OBJECTIVE: Antiretroviral-naive HIV-positive individuals contribute to the transmission of drug-resi...
Background. Drug resistance mutations (DRMs) can serve as distinct, nonpolymorphic markers for evalu...
International audienceOBJECTIVE:Antiretroviral-naive HIV-positive individuals contribute to the tran...
OBJECTIVES: To monitor HIV-1 transmitted drug resistance (TDR) in a well defined urban area with lar...
The effects of drug resistance on HIV-1 replication capacity have been studied, but data from clinic...
We evaluated the predictive value of baseline HIV-1 genotypic resistance mutations for failure of a ...
We characterized 16 additional mutations in human immunodeficiency virus type 1 (HTV-1) reverse tran...